FORE BIOTHERAPEUTICS

fore-biotherapeutics-logo

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.

#SimilarOrganizations #People #Financial #Event #Website #More

FORE BIOTHERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Personal Health

Founded:
2011-01-01

Address:
Jerusalem, Yerushalayim, Israel

Country:
Israel

Website Url:
http://www.fore.bio

Total Employee:
11+

Status:
Active

Contact:
972 2 500 1100

Email Addresses:
[email protected]

Total Funding:
91.5 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Google Maps Google Google Maps API Google Cloud Amazon Route 53 Amazon S3


Similar Organizations

haodfcom-logo

Haodf.com

Haodf.com Provides Internet Medical Platforms.

metabolomic-diagnostics-logo

Metabolomic Diagnostics

Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.


Current Advisors List

charles-woler_image

Charles Woler Board of Director @ Fore Biotherapeutics
Board_member

matthew-foy_image

Matthew Foy Board Member @ Fore Biotherapeutics
Board_member
2020-07-01

Current Employees Featured

gabi-tarcic_image

Gabi Tarcic
Gabi Tarcic Chief Technology Officer @ Fore Biotherapeutics
Chief Technology Officer

stacie-shepherd_image

Stacie Shepherd
Stacie Shepherd CMO @ Fore Biotherapeutics
CMO

matthew-ros_image

Matthew Ros
Matthew Ros Chief Executive Officer @ Fore Biotherapeutics
Chief Executive Officer
2022-04-01

nora-e-brennan_image

Nora E Brennan
Nora E Brennan Chief Financial Officer @ Fore Biotherapeutics
Chief Financial Officer

michael-vidne_image

Michael Vidne
Michael Vidne Chief Business & Strategy Officer @ Fore Biotherapeutics
Chief Business & Strategy Officer

Founder


haim-gil-ad_image

Haim Gil-ad

yoram-altschuler_image

Yoram Altschuler

Investors List

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series C - Fore Biotherapeutics

hbm-partners_image

HBM Partners

HBM Partners investment in Series C - Fore Biotherapeutics

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series C - Fore Biotherapeutics

pontifax_image

Pontifax

Pontifax investment in Series C - Fore Biotherapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Fore Biotherapeutics

wellington-management_image

Wellington Management

Wellington Management investment in Series C - Fore Biotherapeutics

sr-one_image

SR One

SR One investment in Series C - Fore Biotherapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series C - Fore Biotherapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Fore Biotherapeutics

helsinn-investment-fund_image

3B Future Health Fund

3B Future Health Fund investment in Venture Round - Fore Biotherapeutics

Key Employee Changes

Date New article
2022-04-18 Fore Biotherapeutics Appoints Matthew E. Ros as Chief Executive Officer

Official Site Inspections

http://www.fore.bio Semrush global rank: 6.48 M Semrush visits lastest month: 970

  • Host name: 151.101.2.159
  • IP address: 151.101.2.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Fore Biotherapeutics"

Fore Biotherapeutics

Our lead program focuses on plixorafenib, an investigational, next-generation BRAF inhibitor identified by our platform for its ability to inhibit a wide range of BRAF gene alterations in …See details»

Company - Fore Biotherapeutics

About Us We are a precision oncology company using functional genomics to pioneer treatments that improve the lives of patients with rare cancers. Read more. Leadership As experts in …See details»

About Us - Fore Biotherapeutics

Fore Bio is a next-generation precision oncology company. Using our functional genomics platform, we are hyper-targeting therapies to unaddressed tumor mutations to benefit patients with few therapeutic alternatives.See details»

Fore Biotherapeutics - Crunchbase Company Profile & Funding

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics. The company is creating a pipeline of precision oncology treatments …See details»

Fore Biotherapeutics - LinkedIn

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics. Deeply rooted in science and innovation, our vision is to...See details»

FORE Biotherapeutics Names William R. Hinshaw as Chief …

PHILADELPHIA, February 29, 2024 -- (BUSINESS WIRE)--FORE Biotherapeutics today announced the appointment of William R. Hinshaw as the Chief Executive Officer and Director …See details»

Fore Bio lands in Philadelphia - PharmaLive

Jun 15, 2021 · Fore Biotherapeutics (formerly NovellusDx) announced in May that the precision oncology company is opening its global headquarters in Philadelphia’s biotech hub, which is rapidly becoming one of the nation’s …See details»

FORE Biotherapeutics Names Michael Byrnes as CFO - FirstWord …

Aug 12, 2024 · Fore Bio is a precision oncology company dedicated to developing innovative treatments that provide better outcomes for patients with the hardest-to-treat cancers. The …See details»

Leadership - Fore Biotherapeutics

As experts in functional genomics working with executives who have successfully brought multiple new medicines to patients, we are poised to rapidly translate our deep knowledge and experience into effective and targeted therapies. …See details»

Fore Biotherapeutics Opens U.S. Headquarters in …

May 10, 2021 · Fore is pioneering a novel approach to cancer drug development by using functional genomics screening to match patients with rare cancer mutations to clinically validated therapies.See details»

Novellus becomes Fore Biotherapeutics as it completes pivot from ...

Feb 22, 2021 · Now, it’s wrapping its transformation up with a new name and a new CEO: Fore Biotherapeutics and Usama Malik, a former Immunomedics executive who orchestrated the …See details»

Fore Biotherapeutics Opens U.S. Headquarters in Philadelphia …

May 10, 2021 · PHILADELPHIA– (BUSINESS WIRE)–Fore Biotherapeutics (formerly NovellusDx), a precision oncology company focused on providing people with rare cancer …See details»

Fore Biotherapeutics to Present Phase 1/2a Data on ... - Business …

Aug 9, 2022 · Fore Bio is a clinical-stage precision oncology biotechnology company focused on developing treatments for patients with genetically defined cancers whose current treatment …See details»

News - Fore Biotherapeutics

Oct 8, 2024 · Press Release Nov 07 2024 FORE Biotherapeutics to Participate in Upcoming Investor Conferences Read more. Latest posts: Fore Biotherapeutics…See details»

Fore Biotherapeutics Company Profile 2024: Valuation, Funding ...

Operator of a clinical-stage biotechnology company intended to develop selective medicines for functionally and genomically defined cancer patients.See details»

Fore Biotherapeutics Continues to Build Leadership Team with …

Sep 20, 2021 · Fore’s integrated functional genomics and machine learning capabilities, known as Foresight, are elucidating disease biology in competitively distinct and unparalleled ways that …See details»

People - Fore Biotherapeutics

At Fore, our culture is centered around both people and science, with the goal of improving and lengthening the lives of countless individuals throughout the world. We believe that our …See details»

Fore Biotherapeutics Presents Positive Interim Data From Phase …

Sep 12, 2022 · Fore Bio is a precision oncology company dedicated to developing innovative treatments that provide a better outcome for cancer patients. Its lead asset FORE8394 is a …See details»

Biotechnology Innovation Organization | BIO

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»

Clinical Trials - Fore Biotherapeutics

Fore has put measures in place to facilitate access to plixorafenib clinical trials for all eligible participants through a number of strategies.See details»

linkstock.net © 2022. All rights reserved